We are a consortium of seven partners on a joint mission to develop better-tailored vaccines against viral diseases in adults aged 65 years or older. Our aim is to lower the morbidity and mortality burdens in this age class. The project is named “ISOLDA”, acronym for Improved vaccination Strategies for OLDer Adults.